Eleftherios P Mamounas

11PUBLICATIONS

103CO-AUTHORS

Radiation therapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Rehabilitation engineering

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 08, 2026

Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies.

|Sep 10, 2024

Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery.

Patricia A Ganz, Reena S Cecchini, Julia R White

|Jul 24, 2024

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial.

Priya Rastogi, Hanna Bandos, Peter C Lucas

|Jun 04, 2024

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.

Mariana Chavez-MacGregor, Jieling Miao, Lajos Pusztai

|Feb 20, 2024

Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.

Eleftherios P Mamounas, Hanna Bandos, Priya Rastogi

|Feb 09, 2024

Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).

Charles E Geyer, Joanne L Blum, Greg Yothers

Pageof 2

Frequent Collaborators

Norman Wolmark

Soonmyung Paik

Charles E Geyer

Priya Rastogi

Peter C Lucas

Adam M Brufsky

Sandra M Swain

Stephen K L Chia

Matthew P Goetz

Louis Fehrenbacher

Frequent Collaborators

Norman Wolmark

Soonmyung Paik

Charles E Geyer

Priya Rastogi